1
Return

Inactivation of interleukin-15 reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice

delete2026-08-05
delete0
delete
OA
AI
A
Anna Lee
M
Mark Fuller
Y
Yu Chang David Wang
M
Melissa E. MacDonald
N
Nicole L. Batenburg
S
Suleiman A. Igdoura
C
Carl D. Richards
A
Ali A. Ashkar
B
BL Bernardo L. Trigatti *
DOI:10.3389/fphys.2026.1859434delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
IntroductionInterleukin (IL)-15 is essential for the survival and maturation of natural killer (NK) and CD8+ T cells; and it directly activates macrophages.MethodsIn the present study; we examined the effects of inactivating Il-15 on atherosclerosis in apolipoprotein (apo) E-deficient mice.Results and discussionAs expected; Il-15 deficiency reduced circulating NK and CD8+ T cells in ApoE−/− mice. It also increased body weights in female but not male ApoE−/− mice and increased plasma total cholesterol levels in both. Despite this; the Il-15 knockout reduced spontaneous atherosclerotic plaque development in both male and female ApoE−/− mice (fed a normal diet) at 25 weeks of age; and in female normal diet-fed ApoE−/− mice at 15 weeks but not at 38 weeks of age. Furthermore; Il-15 knockout did not impact the levels of atherosclerosis in 25-week-old female ApoE−/− mice fed a high-fat; high-cholesterol diet for 15 weeks. However; the 6-week treatment with an antibody (M96) that blocks IL-15’s interaction with the IL-2Rβγc complex but does not interfere with its interaction with IL-15Rα reduced spontaneous atherosclerosis in female ApoE−/− mice. ApoE knockout mice in which IL-15 was inactivated or neutralized with an antibody exhibited reduced accumulation of CD11b+ and CD8+ cells within atherosclerotic plaques. These findings demonstrate that interfering with IL-15 signaling through the IL-2Rβγc complex delays spontaneous atherosclerosis development in ApoE-deficient mice.
Keywords:
inflammation
atherosclerosis
knockout mouse
interleukin-15 (IL-15)
antibody-based therapeutic

Journal

Frontiers in Physiology cover
Frontiers in Physiology
IF:
3.4
Papers:
1.9W
Citations:
6.2W

Organization

D
department of biology
Scholars:
2.5K
Papers: 1.2K
Citations: 2
D
D
Department of Medicine
Scholars:
8.1K
Papers: 3.4K
Citations: 33
Cited Papers

Cited Papers

Citing Papers

Citing Papers